Eva Cwynar, MD
Opted out of Medicare from February 2017 to February 2027. Internal Medicine, Endocrinology, Diabetes & Metabolism (MD) in Beverly Hills, California, licensed in CA, with an NPI issued in March 2007. Part D covered 524 prescriptions written in 2024, 65% of them generic. Novo Nordisk Inc was the largest of 13 companies reporting payments in 2025, $821.62 in all, mostly food and beverage.
Overview
| NPI | 1558487835 |
|---|---|
| Status | Active |
| Entity type | Individual |
| Credential | MD |
| Sole proprietor | No |
| NPI issued | Mar 21, 2007 |
| Last updated in NPPES | Jul 8, 2007 |
Specialties and licenses
| Taxonomy | Code | License | State |
|---|---|---|---|
| Internal Medicine, Endocrinology, Diabetes & Metabolism Primary | 207RE0101X | A47799 | CA |
Exclusion screening
| List | Result | Details |
|---|---|---|
| HHS-OIG LEIE · Oct 9, 2026 | No match | Checked by NPI and by name + state |
| North Carolina Medicaid · Nov 10, 2026 | No match | — |
| New York OMIG · Nov 10, 2026 | No match | — |
| Ohio Medicaid · Nov 10, 2026 | No match | — |
| Pennsylvania Medicheck · Nov 10, 2026 | No match | — |
| Washington HCA · Nov 10, 2026 | No match | — |
Official OIG search · How matching works ·Bulk check a roster
Medicare
| Enrollment (PECOS) | Not in the public enrollment file of Oct 1, 2026 |
|---|---|
| Opt-out | Opted out Feb 16, 2017 – Feb 16, 2027 |
| Can order and refer | Yes |
During an opt-out period the provider sees Medicare patients only under private contracts, and Medicare does not pay claims for their services.
Part D prescriptions in 2024
| Prescriptions (claims) | 524 · 641 30-day fills |
|---|---|
| Patients | 46 |
| Total drug cost | $56,587 |
| Generic share | 65% of claims |
Industry payments (Open Payments)
- 2025$821.62 · 36 payments from 13 companies
- 2024$1,109 · 58 payments from 12 companies
Top paying companies in 2025
| Company | Amount | Payments |
|---|---|---|
| Novo Nordisk Inc | $179.24 | 8 |
| Ascendis Pharma Endocrinology Inc | $129.20 | 5 |
| Lilly USA, LLC | $77.17 | 3 |
| Tolmar, Inc. | $68.12 | 3 |
| Pfizer Inc. | $67.11 | 2 |
What the 2025 payments were for
- Food and Beverage$821.62 · 36 payments
Receiving payments does not imply wrongdoing. What Open Payments covers ·original records
Other Internal Medicine, Endocrinology, Diabetes & Metabolism providers in Beverly Hills
- 1437186798
- 1508380965
- 1780893560
- 1720112246
- 1255730685
- 1700038338
- 1538349865
- 1639259328
- 1497996318
- 1538658273
- 1225064884
- 1396057147
All Internal Medicine, Endocrinology, Diabetes & Metabolism providers in California →